Univariate analysis | Multivariate analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|
Variables | Cutt-off | Log rank c2 | p-value | factor | Variable | Cut-off | Hazard Ratio | 95% CI | p-value |
Overall survival | Overall survival | ||||||||
Fibronectin | 2/3 | 4.9 | 0.02 | High score | Fibronectin | 2/3 | 2.6 | 1.2–5.4 | 0.01 |
p53 | 5/6 | 6.4 | 0.01 | High score | p53 | 5/6 | 0.9 | 0.4–2.0 | 0.8 |
Histological type | OCCCa/OHGSeCa | 11.2 | 0.0008 | OHGSeCa | Histological type | OCCCa/OHGSeCa | 0.4 | 0.2–1.1 | 0.07 |
Age | 57/58 | 0.4 | 0.52 | FIGO stage | I/II・III・V | 0.2 | 0.06–0.7 | 0.01 | |
FIGO stage | I/II・III・V | 16.1 | < 0.0001 | II・III・IV | LN metastasis | −/+ | 0.8 | 0.4–1.5 | 0.5 |
Tumor size | 11.1/11.2 | 1.1 | 0.3 | Distant metastasis | −/+ | 0.7 | 0.3–1.6 | 0.4 | |
LN metastasis | −/+ | 7.8 | 0.005 | + | Residual tumor | Present/absent | 0.6 | 0.3–1.2 | 0.2 |
Distant metastasis | −/+ | 8.9 | 0.002 | + | after surgery | ||||
Residual tumor | Present/absent | 8.1 | 0.004 | Present | |||||
after surgery | |||||||||
Progression-free survival | Progression-free survival | ||||||||
Fibronectin | 2/3 | 7.6 | 0.006 | High score | Fibronectin | 2/3 | 3.3 | 1.7–6.4 | 0.0005 |
p53 | 5/6 | 12.2 | 0.0005 | High score | p53 | 5/6 | 1.3 | 0.6–2.8 | 0.6 |
Histological type | OCCCa/OHGSeCa | 16.6 | < 0.0001 | OHSeGCa | Histological type | OCCCa/OHGSeCa | 0.6 | 0.3–1.3 | 0.2 |
Age | 57/58 | 3.9 | 0.04 | 58≦ | Age | 57/58 | 0.8 | 0.4–1.3 | 0.3 |
FIGO stage | I/II・III・V | 32.7 | < 0.0001 | II・III・IV | FIGO stage | I/II・III・V | 0.2 | 0.06–0.5 | 0.001 |
Tumor size | 11.1/11.2 | 0.7 | 0.3 | LN metastasis | −/+ | 0.7 | 0.4–1.2 | 0.2 | |
LN metastasis | −/+ | 14.5 | 0.0001 | + | Distant metastasis | −/+ | 0.5 | 0.2–0.9 | 0.03 |
Distant metastasis | −/+ | 22.1 | < 0.0001 | + | Residual tumor | Present/absent | 0.7 | 0.4–1.3 | 0.3 |
Residual tumors | Present/absent | 10 | 0.001 | Present | after surgery | ||||
after surgery |